AI assistant
ALLSTATE CORP — Director's Dealing 2025
Feb 12, 2025
29991_dirs_2025-02-12_6ff3f4f4-7c66-40c0-bc17-b5798015a4ef.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ALLSTATE CORP (ALL)
CIK: 0000899051
Period of Report: 2025-02-10
Reporting Person: Merten Jesse E (EVP & Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-10 | Common Stock | M | 700 | $100.80 | Acquired | 18815 | Direct |
| 2025-02-10 | Common Stock | M | 19672 | $124.26 | Acquired | 38487 | Direct |
| 2025-02-10 | Common Stock | M | 9730 | $105.08 | Acquired | 48217 | Direct |
| 2025-02-10 | Common Stock | M | 10000 | $122.64 | Acquired | 58217 | Direct |
| 2025-02-10 | Common Stock | S | 27315 | $186.0265 | Disposed | 30902 | Direct |
| 2025-02-10 | Common Stock | S | 8592 | $187.1953 | Disposed | 22310 | Direct |
| 2025-02-10 | Common Stock | S | 2654 | $188.1367 | Disposed | 19656 | Direct |
| 2025-02-10 | Common Stock | S | 1541 | $188.9904 | Disposed | 18115 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-10 | Employee Stock Option (Right to Buy) | $100.80 | M | 700 | Disposed | 2028-01-04 | Common Stock (700) | Direct |
| 2025-02-10 | Employee Stock Option (Right to Buy) | $124.26 | M | 19672 | Disposed | 2030-02-19 | Common Stock (19672) | Direct |
| 2025-02-10 | Employee Stock Option (Right to Buy) | $105.08 | M | 9730 | Disposed | 2031-02-18 | Common Stock (9730) | Direct |
| 2025-02-10 | Employee Stock Option (Right to Buy) | $122.64 | M | 10000 | Disposed | 2032-02-17 | Common Stock (10000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 7484 | Indirect |
Footnotes
F1: Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $185.640 to $186.630. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
F2: Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $186.670 to $187.610. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
F3: Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $187.670 to $188.615. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
F4: Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $188.830 to $189.740. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
F5: Stock option award granted on February 17, 2022, for 22,879 shares of common stock vesting in three equal increments. The remaining increment will vest on February 17, 2025.